Executive Summary: Key Legal and Evidentiary Issues

• Dr. Cyr sought judicial review of Vitalité's December 16, 2025 decision suspending her privileges for twelve months and imposing an indefinite supervision condition.
• Procedural fairness was a central issue, since the Board relied solely on the Review Panel's report and ten-minute oral submissions without otherwise hearing the parties.
• Reasonableness of the decision was also disputed, as the Review Panel's report offered no findings of fact, no credibility assessment, and no explanation for its negligence conclusion.
• Evidentiary gaps included the Report's failure to resolve contradictory witness testimony and its disregard of the uncontradicted expert opinion of Dr. Lasher.
• Justice Hamou found both a breach of procedural fairness and an unreasonable decision, quashing the Board's decision along with the Review Panel's report.
• Costs of $6,500 were awarded to Dr. Cyr, and the matter was remitted for fresh determination.

Facts of the case

Dr. Valérie-Anne Cyr applied for judicial review of a December 16, 2025 decision by Vitalité Health Network's Board of Directors, which suspended her medical privileges for twelve months and imposed an indefinite condition of indirect supervision. The Board's decision followed the death of a patient during Dr. Cyr's shift at Stella-Maris-de-Kent Hospital on January 27, 2025. Dr. Cyr, then in the fourteenth hour of a twenty-hour shift, was notified by a nurse of a 33-year-old female patient presenting with chest pain and a history of myocarditis. She assessed the situation by telephone and directed the nurse to conduct a cardiac workup, ECG, and blood tests. When the patient's condition deteriorated, Dr. Cyr attended her bedside to begin resuscitation, but the patient died in the Emergency Department. Vitalité removed Dr. Cyr from the schedule and opened an investigation; a Review Panel later held a three-day hearing in October 2025, heard from ten witnesses (including Dr. Cyr, four physicians, four nurses, and an expert witness), and concluded that Dr. Cyr had been negligent. The Board adopted the Review Panel's report and recommendations in their entirety on December 16, 2025, without providing independent reasons.

Bylaw provisions at issue

Vitalité's Bylaws set out the process for handling complaints and discipline against medical staff. Sections C.7.0 and C.8.0 govern how a complaint is assessed, while section C.10 provides for a Review Panel where a matter is not resolved earlier. Sections C.11 and C.12 direct the Review Panel's hearing procedures, and section C.11.0.5 requires the Panel to prepare a written report containing its conclusions, recommendations, and related reasons. Under section C.13, the Board reviews that report and renders a final, binding decision; section C.13.0.2 provides that parties are not entitled to a formal hearing before the Board, though section C.13.0.6 allows the Board to compel a formal hearing if it is not satisfied it has sufficient information. In this case, the Board held no such hearing, relying instead on the Review Panel's report and brief submissions from counsel.

The court's reasoning

The Court first determined that both the Review Panel's report and the Board's decision were subject to review, since the Board had adopted the report without independent reasons, following the approach taken in Comité exécutif du Collège des médecins du Québec c Pilorgé. On procedural fairness, the Court applied the factors from Baker v Canada (Minister of Citizenship and Immigration) and found that the nature of the decision, the absence of a right of appeal, and the impact on Dr. Cyr's ability to work all called for a higher degree of procedural protection. The Court held that the Board breached procedural fairness by failing to hear Dr. Cyr in any meaningful way, noting that the Board could not delegate its duty to hear the affected party to the Review Panel. Turning to reasonableness under Canada (Minister of Citizenship and Immigration) v Vavilov, the Court found the Review Panel's three-page report, and its five paragraphs of analysis, lacked a discernable chain of reasoning: it contained bare conclusions of negligence, failed to identify which witnesses were relied upon or how conflicting testimony was resolved, disregarded the uncontradicted expert evidence of Dr. Lasher without explanation, and offered no justification for the twelve-month suspension. On this basis, the Court concluded the decision was both procedurally unfair and unreasonable.

Ruling and outcome

The Court granted Dr. Cyr's application for judicial review, quashing the Board's December 16, 2025 decision along with the Review Panel's report, and remitted the matter for determination in accordance with the Court's directions. The Court also held that, because the decision was quashed, it and the resulting suspension no longer form part of Vitalité's records or trigger reporting obligations, though it noted that the underlying complaint and discipline process may still proceed. On costs, the Court applied a multiplier to the standard range under Rule 59, Tariff "E," and ordered Vitalité to pay Dr. Cyr costs of $6,500, inclusive of disbursements. No damages award was made in this decision — the $6,500 figure relates to costs on the application, not compensatory damages.